Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
US7135452B1 · kind B1 · utility
1Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2000 |
| Grant date | Nov 14, 2006 |
| Priority date | — |
| Expiry date | Jan 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant surfactant protein A and pharmaceutical compositions based thereon are useful for the prevention or treatment of pulmonary infection and inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.